Stereotaxis (STXS) Common Equity (2010 - 2026)
Stereotaxis (STXS) posted quarterly Common Equity of $14.4 million for Q1 2026, up 398.54% year-over-year from $2.9 million in Q1 2025, and up 6.51% quarter-over-quarter from $13.5 million in Q4 2025.
Stereotaxis (STXS) Common Equity (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has reported Common Equity for 17 consecutive years, with $14.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Common Equity rose 398.54% year-over-year to $14.4 million; the TTM figure through Mar 2026 stood at $14.4 million (up 398.54% YoY), while the FY2025 annual figure was $13.5 million, up 121.73% from the prior year.
- Common Equity rose to $14.4 million in Q1 2026 per STXS's latest filing, from $13.5 million in the prior quarter.
- Across five years, Common Equity topped out at $32.3 million in Q1 2022 and bottomed at $1.5 million in Q2 2025.
- Historically, Common Equity has averaged $16.3 million across 5 years, with a median of $14.6 million in 2024.
- Annual changes were most pronounced in 2025 — Common Equity plunged 87.18% — and 2026, when it soared 398.54%.
- Stereotaxis' Common Equity stood at $26.3 million in 2022, then plunged by 37.97% to $16.3 million in 2023, then sank by 62.8% to $6.1 million in 2024, then jumped by 121.73% to $13.5 million in 2025, then grew by 6.51% to $14.4 million in 2026.
- Business Quant data shows STXS's Common Equity at $14.4 million in Q1 2026, $13.5 million in Q4 2025, and $6.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 18.30 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 24.42 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 21.60 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 6.59 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 19.08 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 2.99 Bn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 4.80 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 8.24 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 6.21 Bn |
| 10 | Stereotaxis | 141.91 Mn | 127.29 Mn | 3.79 Mn | 14.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.36 Mn |
| Dec 31, 2025 | 13.48 Mn |
| Sep 30, 2025 | 6.27 Mn |
| Jun 30, 2025 | 1.46 Mn |
| Mar 31, 2025 | 2.88 Mn |
| Dec 31, 2024 | 6.08 Mn |
| Sep 30, 2024 | 10.82 Mn |
| Jun 30, 2024 | 11.36 Mn |
| Mar 31, 2024 | 14.57 Mn |
| Dec 31, 2023 | 16.34 Mn |
| Sep 30, 2023 | 18.72 Mn |
| Jun 30, 2023 | 21.39 Mn |
| Mar 31, 2023 | 23.71 Mn |
| Dec 31, 2022 | 26.35 Mn |
| Sep 30, 2022 | 27.77 Mn |
| Jun 30, 2022 | 29.94 Mn |
| Mar 31, 2022 | 32.32 Mn |
| Dec 31, 2021 | 33.84 Mn |
| Sep 30, 2021 | 34.57 Mn |
| Jun 30, 2021 | 36.47 Mn |